As of 2026-09-19, the Relative Valuation of Vaxcyte Inc (PCVX) is (197.15) USD. This relative valuation is based on P/E multiples. With the latest stock price at 58.13 USD, the upside of Vaxcyte Inc based on Relative Valuation is -439.2%.
The range of the Relative Valuation is (176.15) - (215.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 23.8x - 29.3x | 26.6x |
| Forward P/E multiples | 23.9x - 30.0x | 27.0x |
| Fair Price | (176.15) - (215.95) | (197.15) |
| Upside | -403.0% - -471.5% | -439.2% |
| Date | P/E |
| 2026-09-17 | -8.19 |
| 2026-09-16 | -7.97 |
| 2026-09-15 | -8.03 |
| 2026-09-14 | -8.08 |
| 2026-09-11 | -8.07 |
| 2026-09-10 | -7.99 |
| 2026-09-09 | -8.07 |
| 2026-09-08 | -8.19 |
| 2026-09-04 | -8.30 |
| 2026-09-03 | -8.30 |
| 2026-09-02 | -8.36 |
| 2026-09-01 | -8.25 |
| 2026-08-31 | -8.24 |
| 2026-08-28 | -8.12 |
| 2026-08-27 | -8.30 |
| 2026-08-26 | -8.29 |
| 2026-08-25 | -8.29 |
| 2026-08-24 | -8.39 |
| 2026-08-21 | -8.50 |
| 2026-08-20 | -8.32 |
| 2026-08-19 | -8.59 |
| 2026-08-18 | -8.11 |
| 2026-08-17 | -8.17 |
| 2026-08-14 | -7.88 |
| 2026-08-13 | -7.99 |
| 2026-08-12 | -8.09 |
| 2026-08-11 | -8.04 |
| 2026-08-10 | -7.91 |
| 2026-08-07 | -7.88 |
| 2026-08-06 | -7.99 |
| 2026-08-05 | -7.59 |
| 2026-08-04 | -7.42 |
| 2026-08-03 | -7.26 |
| 2026-07-31 | -7.34 |
| 2026-07-30 | -7.59 |
| 2026-07-29 | -7.19 |
| 2026-07-28 | -7.41 |
| 2026-07-27 | -7.53 |
| 2026-07-24 | -7.42 |
| 2026-07-23 | -7.55 |
| 2026-07-22 | -7.60 |
| 2026-07-21 | -7.87 |
| 2026-07-20 | -7.53 |
| 2026-07-17 | -7.63 |
| 2026-07-16 | -7.60 |
| 2026-07-15 | -7.70 |
| 2026-07-14 | -7.63 |
| 2026-07-13 | -7.74 |
| 2026-07-10 | -7.90 |
| 2026-07-09 | -8.12 |